Poonai, N., Mehrotra, S., Mamdani, M., Patmanidis, A., Miller, M., Sukhera, J., & Doan, Q. (2018). The association of exposure to suicide-related Internet content and emergency department visits in children: A population-based time series analysis. Canadian Journal of Public Health = Revue Canadienne de Sante Publique, 108(5-6), e462-e467. (Original work published 2018)

Bhatt, D., Steg, P., Miller, M., Brinton, E., Jacobson, T., Ketchum, S., … REDUCE-IT, I. (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. The New England Journal of Medicine, 380(1), 11-22. https://doi.org/10.1056/NEJMoa1812792 (Original work published 2019)

Ridker, P., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., … Outcome, I. S. C. (2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine, 376(16), 1527-1539. https://doi.org/10.1056/NEJMoa1701488 (Original work published 2017)

Peck, K., Towne, T., Wierenga, C., Hill, L., Eisler, I., Brown, T., … Kaye, W. (2021). Temperament-based treatment for young adults with eating disorders: acceptability and initial efficacy of an intensive, multi-family, parent-involved treatment. Journal of Eating Disorders, 9(1), 110. https://doi.org/10.1186/s40337-021-00465-x (Original work published 2021)

Verma, S., Bhatt, D., Steg, P., Miller, M., Brinton, E., Jacobson, T., … REDUCE-IT, I. (2021). Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation, 144(23), 1845-1855. https://doi.org/10.1161/CIRCULATIONAHA.121.056290 (Original work published 2021)